Mirixa Corp. has been sold to Cardinal Health
First Analysis acted as the exclusive financial advisor in the sale of Mirixa, a leading healthcare technology and services company specializing in medication therapy management (MTM). First Analysis provided advisory expertise to Mirixa throughout the transaction, including preparation, positioning, investor coordination and contact, due diligence and negotiation.
About Mirixa Corp.:
Headquartered in Reston, VA, Mirixa was the leading provider of medication therapy management software solutions. The company’s solution and large pharmacy footprint enabled its customers to successfully engage patients, manage chronic conditions, and improve adherence and clinical outcomes while reducing healthcare costs. Cardinal Health announced that it will integrate the business into OutcomesMTM. The two will combine to offer the highest quality MTM programs for payers and enhance payable service opportunities for MTM providers. Merging MirixaPro and the OutcomesMTM Connect Platform will create efficiencies for pharmacists delivering MTM services to better support them in optimizing medication regimens and reducing medication-related problems for eligible members.